Zeolitic Imidazolate Framework-8 (ZIF-8), for the first time for ZIFs, exhibits a remarkable capacity for the anticancer drug 5-fluorouracil (5-FU), around 660 mg of 5-FU/g of ZIF-8, and presents a pH-triggered controlled drug release property. These prove ZIF-8 to be a valuable candidate for delivery of anticancer agents and reveal its potential applications in the treatment of cancer.

The formation processes of barrier anodic alumina (BAA) and porous anodic alumina (PAA) are discussed in detail. The anodizing current J(T) within the oxide includes ionic current j(ion) and electronic current j(e) during the anodizing process. The j(ion) is used to form an oxide and the j(e) is used to give rise to oxygen gas or sparking. The j(e) results from the impurity centers within the oxide. For a given electrolyte, the j(e) is dependent on the impurity centers and independent of the J(T). The formation of nanopores can be ascribed to the oxygen evolution within the oxide. Oxygen gas will begin to be released at the critical thickness d(c). The manner of the development of PAA is in accordance with that of BAA. The differences between PAA and BAA are the magnitude of j(e) or the continuity of oxygen evolution. There are two competitive reactions, i.e. oxide growth (2Al3 + 3O2- --> Al2O3) and oxygen evolution (2O2- --> O2 up arrow + 4e). The former keeps the wall of the channel lengthened, the latter keeps the channel open. By controlling the release rate of oxygen gas under different pressures, the shape of the channels can be adjusted. The present results may open up some opportunities for fabricating special templates.

A chiral nanoporous metal-organic framework (MOF) with high porosity is obtained based on nontoxic zinc and achiral hexadentate ligand. It shows high drug loading and slow release of the proportion of the loaded drug with a complete delivery time of about one week when used as a material for adsorption and delivery of anticancer 5-fluorouracil.

Benefiting from the unique advantages of MOFs materials, efficient delivery of various kinds of drugs has been achieved in some MOF materials. However, it is only the outset of MOFs in drug delivery system, and numerous work need to be done before clinical applications, for example, studying their in vivo toxicity, exploring degradation mechanisms so as to establish real stability of MOFs in body's liquid, providing appropriated surface modification avenue for MOFs, and researching in vivo efficiency and pharmacokinetics of drug-loaded MOFs.

This review focuses on the properties of POMs used in DSSCs, which are primarily dependent on their electronic structural diversity.